These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 189922)
1. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas. Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922 [No Abstract] [Full Text] [Related]
3. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of sarcomas]. Meuret G Dtsch Med Wochenschr; 1978 Feb; 103(7):308-13. PubMed ID: 342221 [No Abstract] [Full Text] [Related]
5. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report. Takita H; Marabella PC; Edgerton F; Rizzo D Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692 [No Abstract] [Full Text] [Related]
6. Chemotherapy for sarcoma of the stomach. Bedikian AY; Valdivieso M; Khankhanian N; Benjamin RS; Bodey GP Cancer Treat Rep; 1979 Mar; 63(3):411-4. PubMed ID: 427823 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma. Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102 [No Abstract] [Full Text] [Related]
8. Doxorubicin, dacarbazine, vincristine, and cyclophosphamide in the treatment of advanced gastrointestinal leiomyosarcoma. Choi TK; Ng A; Wong J Cancer Treat Rep; 1985 Apr; 69(4):443-4. PubMed ID: 3995513 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU. Einhorn LH; Furnas B Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981 [TBL] [Abstract][Full Text] [Related]
10. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy. Everall JD; Dowd PM Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710 [No Abstract] [Full Text] [Related]
11. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease. Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in disseminated melanoma and other solid tumors in adults. Gerner RE; Moore GE; Dickey C Oncology; 1975; 31(1):22-30. PubMed ID: 1099501 [TBL] [Abstract][Full Text] [Related]
13. Advances in the chemotherapy of soft tissue sarcomas. Benjamin RS; Baker LH; O'Bryan RM; Moon TE; Gottlieb JA Med Clin North Am; 1977 Sep; 61(5):1039-43. PubMed ID: 895246 [No Abstract] [Full Text] [Related]
14. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for benign and locally aggressive tumors: report of two cases. Hensley MF; Cangir A; van Eys J; Goepfert H Cancer Treat Rep; 1978 Jan; 62(1):167-8. PubMed ID: 203394 [No Abstract] [Full Text] [Related]
16. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer. Saiontz HI; Dalton RJ; Eagan RT Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692 [No Abstract] [Full Text] [Related]
17. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide. Azizi F; Bitran J; Javehari G; Herbst AL Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999 [TBL] [Abstract][Full Text] [Related]
18. Alternating administration of adriamycin (NSC-123127) and vincristine (NSC-67574)-actinomycin D (NSC-3053) in advanced sarcomas. Douglass HO; Karakousis C Cancer Chemother Rep; 1975; 59(5):1045-7. PubMed ID: 1106847 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of sarcomas. Wilbur JR; Sutow WW; Sullivan MP; Gottlieb JA Cancer; 1975 Aug; 36(2):765-9. PubMed ID: 1157036 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of metastasising soft-tissue sarcoma with a uniform combination chemotherapy of cyclosphosphamide, vincristin, adriamycin and DTIC ("CyVADIC") (author's transl)]. Schmidt M; Sodomann CP; Gropp C; Havemann K Dtsch Med Wochenschr; 1978 Jul; 103(30):1206-10. PubMed ID: 668561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]